SVP-B5 Peptide from Buthus Martensii Karsch Scorpion Venom Exerts Hyperproliferative Effects on Irradiated Hematopoietic Cells.
Yan Wang,Baiqian Xing,Ting Li,Caixia Wang,Meixun Zhou,Yamin Liu,Lingjie Fan,Lili Hu,Xiang Peng,Yongxin Xiang,Han Wang,Tianhan Kong,Weihua Dong,Qifeng Guo
DOI: https://doi.org/10.3892/etm.2017.5152
IF: 2.7
2017-01-01
Experimental and Therapeutic Medicine
Abstract:Previous studies have demonstrated the radioprotective efficacy of scorpion venom peptide, fraction II (SVPII) from the venom of Buthus martensii Karsch. In the present study, the SVP-B5 polypeptide, which is one of the active components of SVPII, was purified using a two-step chromatographic process. SVP-B5 significantly promoted the proliferation of irradiated M-NFS-60 mouse-derived myelocytic leukemia cells. In addition, SVP-B5 effectively and persistently promoted hematopoietic recovery and expansion of hematopoietic cells after irradiation as demonstrated by cobblestone area forming cell and long-term bone marrow culture assays. Treatment of M-NFS-60 cells with SVP-B5 upregulated the expression of interleukin 3 receptor and activated the Janus kinase-2/signal transducer and activator of transcription 5 signaling pathway. In conclusion, the present study demonstrated that SVP-B5 has growth factor-like properties and may be used as a therapeutic modality in the recovery of severe myelosuppression, which is a common side effect of radiotherapy.